XORTX Therapeutics Inc. submitted Form 6-K on March 26, 2026, reporting their filing obligations with the SEC. This filing is deemed significant for investors as it confirms regulatory compliance.
AI Assistant
XORTX THERAPEUTICS INC
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.